ApprovalTrail

Approval · Notice of Compliance 1942 · 1999

ALOCRIL: Notice of Compliance 1942

Issued December 17, 1999

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1942
Date
December 17, 1999
Company
Allergan IncMarkham, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Admin
Reason
Change in product name
Therapeutic class
Antiallergic

Products in this notice

BrandDINStatus today
ALOCRIL02241407Cancelled Post Market

Medicinal ingredients